回收式自体输血在肝癌肝移植中的应用进展  

Research progress of autotransfusion in liver transplantation for hepatocellular carcinoma

作　　者：孙鑫洲 SUN Xinzhou(Department of Anesthesiology,The First Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,Zhejiang 310003,China)

机构地区：[1]浙江大学医学院附属第一医院麻醉科,浙江杭州310003

出　　处：《医药前沿》2021年第15期22-23,共2页Journal of Frontiers of Medicine

基　　金：浙江省医药卫生科技计划项目(2019-KY1-001-162)。

摘　　要：回收式自体输血是目前临床上对肝癌移植患者术中应用的主要输血方式,该模式的操作原理是将患者术中术后创口出血进行专业的回收、抗凝、洗涤、浓缩处理后,再回输到患者体内。输血方法操作简单,对血液的回收利用率高,治疗成本低。但在实施过程中,极易因操作不当致诱发患者凝血功能发生障碍,肺功能障碍、败血症以及其他严重的合并病症,因此该输血手段的可行性和安全性有待考量。基于此,笔者查阅了多国家多研究中心回收式自体输血在肝癌移植患者中的应用价值文献,现将查阅结果作如下综述,旨在为相关研究和临床应用提供参考。Recovery autologous blood transfusion is currently the main clinical blood transfusion method used in liver cancer transplant patients.The operating principle of this mode is to professionally recover,anticoagulate,wash,and concentrate the bleeding from the wound during and after the operation.,And then return to the patient's body.The blood transfusion method is simple to operate,has a high recovery rate of blood,and has a low treatment cost.However,during the implementation process,improper operation can easily induce coagulation disorders,pulmonary dysfunction,sepsis,and other serious comorbidities.Therefore,the feasibility and safety of this blood transfusion method need to be considered.Based on this,the author has reviewed the literature on the application value of recovered autologous blood transfusion in liver cancer transplant patients in many countries and multiresearch centers,and the results of the review are summarized as follows,in order to provide references for related research and clinical applications.

关 键 词：综述 回收式自体输血 肝癌 肝移植 白细胞去除 辐照 

分 类 号：R735.7[医药卫生—肿瘤]